Merit Medical Systems MMSI Therapeutic — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Merit Medical Systems in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Merit Medical Systems’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Merit Medical Systems's therapeutic — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Merit Medical Systems's therapeutic — revenue?
- Merit Medical Systems (MMSI) reported therapeutic — revenue of $126.4M in Q1 2026.
- What does therapeutic — revenue mean?
- This metric represents the total net revenue generated from the sale of products or services within the therapeutic business unit, excluding any sales-based taxes collected from customers. It serves as a primary indicator of the commercial performance and market adoption of the company's specialized therapeutic medical devices. Tracking this revenue stream allows investors to evaluate the growth trajectory and competitive positioning of the firm's specific therapeutic product portfolio.